Pediatric Safety Tests In Juvenile Animals Need Validation, AstraZeneca Says

FDA should confirm whether using juvenile animals to evaluate pediatric drug safety is more predictive of the clinical experience than current practice, AstraZeneca says in comments on a proposed agency guidance